35.11 81.96% Selling expenses 9.20 4.08 5.12 125.49% Administrative expenses 14.60 15.81 (1.21) (7.65%) Finance cost 1.02 0.88 0.14 15.91% Profit before income tax expenses 111.79 33.39 78.40 234.80

on dissolution of Solvay Biochemicals (Taixing) Limited amounting to 89 MB from other comprehensive income to the profit of the year 2018. Summary of Performance For the year 2019, the Company and its

overall sales volume, the Company and its subsidiaries brought 1.6% growth of Gross profit margin versus 2017 by the strong contribution of Epicerol® business. 2. In 2018, distribution costs, administrative

2017. The Company and its subsidiaries have been able to increase the Gross Profit margin by 7% compared to the year 2016. 2. In 2017, distribution costs, administrative expenses, and doubtful debt

the company was able to utilize the deferred tax asset, which was non-cash item. Net Profit Reported net profit of the company for the period of Q3’2018-2019 was Baht 422 million, rose by Baht 130

104.9 2.5 2.4% Cost of sales and services (1,274.4) (1,121.4) (153.0) (12.0%) Gross profit 466.2 350.0 (116.2) (24.9%) Net gain (loss) on exchange rate (17.4) 94.4 111.9 N.A. Gain (loss) on forward

146.47% Profit before income tax expenses 42.67 111.79 (69.11) -61.83% Income tax expenses (revenues) 1.27 0.58 0.69 119.50% Profit for the year 41.40 111.21 (69.81) -62.77% Unrealised gain on revaluation

Company’s net profit decreased by 67.76% or equal to Baht 13.91 million as compared to the same quarter of 2018 which was recorded at Baht 43.14 million. For 1H19, the Company recorded the net profit of Baht

Compare % + (-) Revenues from sales and services 976.46 1,041.05 (64.59) (6.20) Cost of sales and services (754.53) (714.18) (40.34) 5.65 Gross profit 221.94 326.87 (104.93) (32.1) Profit (loss) for the

2019. The Company also had a foreign exchange gain of THB 4.4 million during the year. Gross profit margin from both sales of goods and rental and rendering of services increased from 25.0% to 29.4% due